Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

26 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
PAIS 2 (Paracetamol [Acetaminophen] in Stroke 2): Results of a Randomized, Double-Blind Placebo-Controlled Clinical Trial.
de Ridder IR, den Hertog HM, van Gemert HM, Schreuder AH, Ruitenberg A, Maasland EL, Saxena R, van Tuijl JH, Jansen BP, Van den Berg-Vos RM, Vermeij F, Koudstaal PJ, Kappelle LJ, Algra A, van der Worp HB, Dippel DW; Trial Organization. de Ridder IR, et al. Among authors: ruitenberg a. Stroke. 2017 Apr;48(4):977-982. doi: 10.1161/STROKEAHA.116.015957. Epub 2017 Mar 13. Stroke. 2017. PMID: 28289240 Clinical Trial.
Paracetamol (Acetaminophen) in stroke 2 (PAIS 2): protocol for a randomized, placebo-controlled, double-blind clinical trial to assess the effect of high-dose paracetamol on functional outcome in patients with acute stroke and a body temperature of 36.5 °C or above.
de Ridder IR, de Jong FJ, den Hertog HM, Lingsma HF, van Gemert HM, Schreuder AH, Ruitenberg A, Maasland EL, Saxena R, Oomes P, van Tuijl J, Koudstaal PJ, Kappelle LJ, Algra A, van der Worp HB, Dippel DW. de Ridder IR, et al. Among authors: ruitenberg a. Int J Stroke. 2015 Apr;10(3):457-62. doi: 10.1111/ijs.12053. Epub 2013 May 22. Int J Stroke. 2015. PMID: 23692587 Clinical Trial.
[Does paracetamol improve recovery after stroke?].
de Ridder IR, van der Worp HB, van Gemert HM, Schreuder AH, Ruitenberg A, Maasland EL, Saxena R, Dippel DW. de Ridder IR, et al. Among authors: ruitenberg a. Ned Tijdschr Geneeskd. 2011;155(46):A4169. Ned Tijdschr Geneeskd. 2011. PMID: 22108464 Dutch.
Second intravenous immunoglobulin dose in patients with Guillain-Barré syndrome with poor prognosis (SID-GBS): a double-blind, randomised, placebo-controlled trial.
Walgaard C, Jacobs BC, Lingsma HF, Steyerberg EW, van den Berg B, Doets AY, Leonhard SE, Verboon C, Huizinga R, Drenthen J, Arends S, Budde IK, Kleyweg RP, Kuitwaard K, van der Meulen MFG, Samijn JPA, Vermeij FH, Kuks JBM, van Dijk GW, Wirtz PW, Eftimov F, van der Kooi AJ, Garssen MPJ, Gijsbers CJ, de Rijk MC, Visser LH, Blom RJ, Linssen WHJP, van der Kooi EL, Verschuuren JJGM, van Koningsveld R, Dieks RJG, Gilhuis HJ, Jellema K, van der Ree TC, Bienfait HME, Faber CG, Lovenich H, van Engelen BGM, Groen RJ, Merkies ISJ, van Oosten BW, van der Pol WL, van der Meulen WDM, Badrising UA, Stevens M, Breukelman AJ, Zwetsloot CP, van der Graaff MM, Wohlgemuth M, Hughes RAC, Cornblath DR, van Doorn PA; Dutch GBS Study Group. Walgaard C, et al. Lancet Neurol. 2021 Apr;20(4):275-283. doi: 10.1016/S1474-4422(20)30494-4. Epub 2021 Mar 17. Lancet Neurol. 2021. PMID: 33743237 Clinical Trial.
Inflammatory proteins in plasma and the risk of dementia: the rotterdam study.
Engelhart MJ, Geerlings MI, Meijer J, Kiliaan A, Ruitenberg A, van Swieten JC, Stijnen T, Hofman A, Witteman JC, Breteler MM. Engelhart MJ, et al. Among authors: ruitenberg a. Arch Neurol. 2004 May;61(5):668-72. doi: 10.1001/archneur.61.5.668. Arch Neurol. 2004. PMID: 15148142
Incidence of dementia: does gender make a difference?
Ruitenberg A, Ott A, van Swieten JC, Hofman A, Breteler MM. Ruitenberg A, et al. Neurobiol Aging. 2001 Jul-Aug;22(4):575-80. doi: 10.1016/s0197-4580(01)00231-7. Neurobiol Aging. 2001. PMID: 11445258
26 results